Skip to main content
Erschienen in: Clinical Rheumatology 11/2007

01.11.2007 | Case Report

Cardiac sarcoidosis responding to monotherapy with infliximab

verfasst von: Imad Uthman, Zahi Touma, Maurice Khoury

Erschienen in: Clinical Rheumatology | Ausgabe 11/2007

Einloggen, um Zugang zu erhalten

Abstract

Cardiac involvement is a rare and potentially life-threatening complication of sarcoidosis. We report the case of a young previously healthy woman who presented with complete atrioventricular heart block. Further evaluation revealed non-caseating granulomas in the hilar and mediastinal regions. A pacemaker was inserted, and she was treated with four doses of infliximab after she refused treatment with steroids. Rapid resolution of the pulmonary lymph nodes was documented and repeated interrogations of the pacemaker 1 year after her last infliximab infusion documented that she was in sinus rhythm. Infliximab may be considered as an alternative first-line therapy in sarcoidosis with serious organ involvement.
Literatur
1.
Zurück zum Zitat Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef Chapelon-Abric C, de Zuttere D, Duhaut P, Veyssier P, Wechsler B, Huong DL et al (2004) Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83:315–334CrossRef
2.
Zurück zum Zitat Veinot JP, Johnston B (1998) Cardiac sarcoidosis—an occult cause of sudden death: a case report and literature review. J Forensic Sci 43:715–717PubMed Veinot JP, Johnston B (1998) Cardiac sarcoidosis—an occult cause of sudden death: a case report and literature review. J Forensic Sci 43:715–717PubMed
3.
Zurück zum Zitat Sharma OP (2003) Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 123:18–19PubMedCrossRef Sharma OP (2003) Diagnosis of cardiac sarcoidosis: an imperfect science, a hesitant art. Chest 123:18–19PubMedCrossRef
4.
5.
Zurück zum Zitat Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed Silverman KJ, Hutchins GM, Bulkley BH (1978) Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 58:1204–1211PubMed
6.
Zurück zum Zitat Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed Iwai K, Sekiguti M, Hosoda Y, DeRemee RA, Tazelaar HD, Sharma OP et al (1994) Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis 11:26–31PubMed
7.
Zurück zum Zitat Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53PubMedCrossRef Prior C, Knight RA, Herold M, Ott G, Spiteri MA (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53PubMedCrossRef
8.
Zurück zum Zitat Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ (2002) TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol 168:4620–4627PubMed
9.
Zurück zum Zitat Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74PubMed Baughman RP, Lower EE (2001) Infliximab for refractory sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18:70–74PubMed
10.
Zurück zum Zitat Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542–3543PubMedCrossRef Ulbricht KU, Stoll M, Bierwirth J, Witte T, Schmidt RE (2003) Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis. Arthritis Rheum 48:3542–3543PubMedCrossRef
11.
Zurück zum Zitat Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMedCrossRef Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071PubMedCrossRef
12.
Zurück zum Zitat Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277–279PubMedCrossRef Carter JD, Valeriano J, Vasey FB, Bognar B (2004) Refractory neurosarcoidosis: a dramatic response to infliximab. Am J Med 117:277–279PubMedCrossRef
13.
Zurück zum Zitat Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31PubMed Yee AM, Pochapin MB (2001) Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 135:27–31PubMed
14.
Zurück zum Zitat Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef Baughman RP, Drent M, Kavuru M, Judson MA, Costabel U, du Bois R et al (2006) Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med 174:795–802PubMedCrossRef
15.
Zurück zum Zitat Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133–3140PubMedCrossRef Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT (2003) Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF therapy against congestive heart failure (ATTACH) trial. Circulation 107:3133–3140PubMedCrossRef
Metadaten
Titel
Cardiac sarcoidosis responding to monotherapy with infliximab
verfasst von
Imad Uthman
Zahi Touma
Maurice Khoury
Publikationsdatum
01.11.2007
Verlag
Springer-Verlag
Erschienen in
Clinical Rheumatology / Ausgabe 11/2007
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-007-0614-1

Weitere Artikel der Ausgabe 11/2007

Clinical Rheumatology 11/2007 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.